BioLife Solutions to Attend and Present at Upcoming Investor Conferences

Rhea-AI Summary

BioLife Solutions, a key player in bioproduction for cell and gene therapies, has announced that its leadership team, including CEO Mike Rice, COO Rod de Greef, and CFO Troy Wichterman, will present at two major investor conferences in March 2022. The first is the Cowen 42nd Annual Health Care Conference on March 9, and the second is the KeyBanc Life Sciences & MedTech Forum on March 23. These events will showcase BioLife's innovations and strategies in the biopharma market.

BOTHELL, Wash., March 1, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies (CGT) and the broader biopharma markets, today announced Mike Rice, Chairman and CEO, Rod de Greef, President and COO, and Troy Wichterman, CFO, are scheduled to present at both the Cowen and KeyBanc Investor Conferences in March 2022.

COWEN 42^nd Annual Health Care Conference (Virtual)
Track 12
Wednesday, March 9^th
12:50-1:20pm ET 
https://www.cowen.com/conferences-and-events/42nd-annual-health-care-conference/

KeyBanc Life Sciences & MedTech Forum
Fireside Chat
Wednesday, March 23^rd
4:30pm ET

About BioLife Solutions

BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets. Our tools portfolio includes our proprietary CryoStor® and HypoThermosol^Ò biopreservation media for shipping and storage, the ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system,  high capacity cryogenic storage freezers, Stirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools.  For more information, please visit www.biolifesolutions.com, www.scisafe.com, www.stirlingultracold.com, or www.sextonbio.com and follow BioLife on Twitter.

Media & Investor Relations

At the Company

Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com

Investors

LHA Investor Relations
Jody Cain
(310) 691-7100
jcain@lhai.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-attend-and-present-at-upcoming-investor-conferences-301492598.html

SOURCE BioLife Solutions, Inc.

FAQ

When will BioLife Solutions present at the Cowen Conference?

BioLife Solutions will present at the Cowen 42nd Annual Health Care Conference on March 9, 2022, from 12:50 PM to 1:20 PM ET.

What is the date of BioLife Solutions' presentation at the KeyBanc Forum?

The presentation at the KeyBanc Life Sciences & MedTech Forum is scheduled for March 23, 2022, at 4:30 PM ET.

Who are the speakers representing BioLife Solutions at the upcoming conferences?

The speakers from BioLife Solutions include Mike Rice (Chairman and CEO), Rod de Greef (President and COO), and Troy Wichterman (CFO).

What are the key areas of focus for BioLife Solutions at these investor conferences?

BioLife Solutions will focus on its bioproduction products and services for cell and gene therapies and the broader biopharma markets during the investor conferences.

What is the stock ticker symbol for BioLife Solutions?

The stock ticker symbol for BioLife Solutions is BLFS.